Literature DB >> 6128763

Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases.

D G Scott, P A Bacon, P J Elliott, C R Tribe, T B Wallington.   

Abstract

Between 1972 and 1980 a histological diagnosis of vasculitis was made on 80 patients from a district general hospital. These were divided into a polyarteritis nodosa (PAN) group, a rheumatoid vasculitis (RV) group and a heterogeneous group of other vasculitides. There was considerable overlap between the clinical and laboratory features in the three groups. Non-specific symptoms (fever and myalgia), leucocytosis and eosinophilia were the most useful features for distinguishing PAN from the other two groups. Hepatitis B infection was rare (two patients) and hypocomplementaemia was a feature of RV but not of PAN. The overall mortality was similar in each group. However, in PAN deaths due to vasculitis were more common within six months of diagnosis. Features associated with a poor prognosis were renal impairment, cutaneous and intestinal vasculitis in PAN; and neuropathy, weight loss and histological evidence of vasculitis at rectal biopsy in RV. Cytoxic drugs combined with corticosteroids were associated with an improved prognosis compared with corticosteroids alone in the PAN group. Pulmonary involvement was associated with less severe renal disease but with a six month mortality similar to that in the whole PAN group. Systemic vasculitis is not uncommon in a district general hospital population. The overlapping clinical and laboratory features in different vasculitic diseases stress the problems in classification between PAN and other groups. Patients with systemic disease complicated by necrotizing arteritis have a severe, life threatening disease which may respond to aggressive cytotoxic therapy.

Entities:  

Mesh:

Year:  1982        PMID: 6128763

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  20 in total

Review 1.  Central nervous system polyarteritis nodosa.

Authors:  M R Rosenberg; M Parshley; S Gibson; R Wernick
Journal:  West J Med       Date:  1990-11

Review 2.  Neurology of the vasculitides and connective tissue diseases.

Authors:  P M Moore; B Richardson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

3.  Microscopic polyarteritis: clinical features and treatment.

Authors:  H Rodgers; J A Guthrie; A M Brownjohn; J H Turney
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

Review 4.  The aetiology and pathogenesis of major systemic vasculitides.

Authors:  C O Savage; Y C Ng
Journal:  Postgrad Med J       Date:  1986-07       Impact factor: 2.401

5.  Systemic vasculitis in a rheumatology unit over a two year period.

Authors:  M McDermott; S O'Mahony; M G Molloy
Journal:  Ir J Med Sci       Date:  1987-11       Impact factor: 1.568

6.  Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration.

Authors:  C R Hind; C O Savage; C G Winearls; M B Pepys
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

Review 7.  The necrotising vasculitides.

Authors:  E H Sawicka
Journal:  Thorax       Date:  1987-12       Impact factor: 9.139

8.  Diagnostic relevance of fibronectin in cryoprecipitates.

Authors:  M W Robinson; K W Walton; D G Scott; D L Scott
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

9.  Precipitating antibodies to nuclear antigens in systemic vasculitis.

Authors:  D G Scott; R P Skinner; P A Bacon; P J Maddison
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

Review 10.  Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis.

Authors:  Aman Sharma; Kusum Sharma
Journal:  J Clin Exp Hepatol       Date:  2013-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.